K14dNLef1 Mouse

In vivo study of Lef1 activity in skin; model for hair growth & follicle formation; disease model for skin tumour formation (sebaceous adenoma, sebeoma, squamous papilloma)

Contributors

Inventor Institute
Fiona Watt Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Cat. #: 151564
Cancer types: Skin cancer
Research Fields: Cancer;Cell signaling and signal transduction;Developmental biology;Genetics;Stem cell biology
Target: Lef1 N-terminal mutant (constituitive transcirptional activity)
Disease: Cancer
Phenotype: Tumourigenesis (skin); skin abnormalities (hair follicle, sebaceous gland)
Product description: In vivo study of Lef1 activity in skin; model for hair growth & follicle formation; disease model for skin tumour formation (sebaceous adenoma, sebeoma, squamous papilloma)
Conditional: Yes
Conditional description: Conditional expression of deltaN-Lef1 under Keratin 14 promoter giving tissue-specific epidermal expression.
Genetic background: A deltaNLef1 transgene vector, containing an N-terminally deleted mouse Lef1 cDNA under the control of the keratin 14 promoter, was injected into fertilised CBA/C57BL6 ooctyes. Founders were backcrossed to establish transgenic lines.
Production details: A deltaNLef1 transgene vector, containing an N-terminally deleted mouse Lef1 cDNA under the control of the keratin 14 promoter, was injected into fertilised CBA/C57BL6 ooctyes. Founders were backcrossed to establish transgenic lines.
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Niemann et al. 2002. Development. 129(1):95-109. PMID: 11782404.

Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours.

Related Tools for Mouse models

Cat. # Tool Name
151442 Inva5b1 Mouse Key Info View Tool
151518 Lupus Mouse Key Info View Tool
151519 BRaf1 KI Mouse Key Info View Tool
151534 Pdgfrb-Cre Mouse Key Info View Tool
151550 Integrin a6b4 Mouse Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.